Environmental risk factors for autism

Emerging Health Threats Journal

Volumn 4, Issue 1, 2011, Pages

  Dietert, Rodney R ^a   Dietert, Janice M ^b   DeWitt, Jamie C ^c  

^a Department of Obstetrics Gynecology   (United States)

^b Performance Plus Consulting   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Autism; Autism spectrum disorders; Critical windows of development; Developmental neurotoxicity testing; Drugs; Environmental chemicals; Infections; Stressors; Vaccinations

Indexed keywords

ANTIPYRETIC AGENT; ARSENIC; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FOLIC ACID; HEAVY METAL; LEAD; MANGANESE; MERCURY; MISOPROSTOL; PESTICIDE; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; SOLVENT; THALIDOMIDE; VALPROIC ACID; VITAMIN D;

AUTISM; CHILDHOOD DISINTEGRATIVE DISORDER; DIET; DIFFERENTIAL DIAGNOSIS; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL IMPACT; EPIGENETICS; GENOTYPE ENVIRONMENT INTERACTION; HEALTH HAZARD; HUMAN; INCIDENCE; INFECTION; MEDICAL RESEARCH; NEUROTRANSMISSION; NONHUMAN; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RETT SYNDROME; REVIEW; RISK FACTOR; SAFETY; SOCIAL INTERACTION; SOCIOECONOMICS; STRESS; TERATOGENICITY; VACCINATION;

EID: 80052748357     PISSN: 17528550     EISSN: 17528550     Source Type: Journal    
DOI: 10.3402/ehtj.v4i0.7111     Document Type: Review

References (111)

1. Hanson MA, Gluckman PD. Developmental origins of health and disease: New insights. Basic Clin Pharmacol Toxicol. 2008;102:90-3.
2. Dietert RR, Zelikoff JT. Pediatric immune dysfunction and health risks following early life immune insult. Curr Pediatr Rev. 2009;5:36-51.
3. Dietert RR, DeWitt J, Germolec DR, Zelikoff JT. Breaking patterns of environmentally-influenced disease for health risk reduction: Immune perspectives. Environ Health Perspect. 2010;188:1091-9.
4. Landrigan PJ. What causes autism? Exploring the environmental contribution. Curr Opin Pediatr. 2010;22:219-25.
5. Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: Comprehensive meta-analysis. Br J Psychiatry. 2009; 195:7-14.
6. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R. Genetics of autistic disorders: Review and clinical implications. Eur Child Adolesc Psychiatry. 2010;19:169-78.
7. Stilp RL, Gernsbacher MA, Schweigert EK, Arneson CL, Goldsmith HH. Genetic variance for autism screening items in an unselected sample of toddler-age twins. J Am Acad Child Adolesc Psychiatry. 2010;49:267-76.
8. Kogan MD, Blumberg SJ, Schieve LA, Boyle CA, Perrin JM, Ghandour RM, et al. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics. 2009;124:1395-403.
9. DSM-IV. Diagnostic and statistical manual of mental disorders. 4th ed. Arlington, VA: American Psychiatric Association; 2000. 943 p.
10. Kanner L. Autistic disturbances of affective contact. Nervous Child. 1943;2:217-50.
11. DSM-III. Diagnostic and statistical manual of mental disorders. 3rd ed. Arlington, VA: American Psychiatric Association; 1980. 567 p.
12. Centers for Disease Control and Prevention (CDC). Autism and Developmental Disabilities Monitoring Network surveillance year 2006. Principal investigators. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009;58(10):1-20.
13. King M, Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 2009;38:1224-34.
14. Yazbak FE. Autism in the United States: A perspective. J Am Physicians Surg. 2003;8:103-7.
15. Avchen RN, Wiggins LD, Devine O, Van Naarden Braun K, Rice C, Hobson NC, et al. Evaluation of a records-review surveillance system used to determine the prevalence of autism spectrum disorders. J Autism Dev Disord. 2011;41:227-36.
16. Larsson M, Weiss B, Janson S, Sundell J, Bornehag CG. Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6-8 years of age. Neurotoxicology. 2009;30:822-31.
17. Becker KG, Schultz ST. Similarities in features of autism and asthma and a possible link to acetaminophen use. Med Hypotheses. 2010;74:7-11.
18. Curtin C, Anderson SE, Must A, Bandini L. The prevalence of obesity in children with autism: A secondary data analysis using nationally representative data from the National Survey of Children's Health. BMC Pediatr. 2010;10:11.
19. Dietert RR, Dietert JM. Strategies for protecting your child's immune system. Singapore: World Scientific Publications; 2010.
20. Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism. 2009;13:317-36.
21. Lee LC, Harrington RA, Louie BB, Newschaffer CJ. Children with autism: Quality of life and parental concerns. J Autism Dev Disord. 2008;38:1147-60.
22. Montes G, Halterman JS. Child care problems and employment among families with preschool-aged children with autism in the United States. Pediatrics. 2008;122:e202-8.
23. Montes G, Halterman JS. Association of childhood autism spectrum disorders and loss of family income. Pediatrics. 2008;121:e821-6.
24. Estes A, Munson J, Dawson G, Koehler E, Zhou XH, Abbott R. Parenting stress and psychological functioning among mothers of preschool children with autism and developmental delay. Autism. 2009;13:375-87.
25. Goldman SE, Surdyka K, Cuevas R, Adkins K, Wang L, Malow BA. Defining the sleep phenotype in children with autism. Dev Neuropsychol. 2009;34:560-73.
26. Souders MC, Mason TB, Valladares O, Bucan M, Levy SE, Mandell DS, et al. Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep. 2009;32:1566-78.
27. Glickman G. Circadian rhythms and sleep in children with autism. Neurosci Biobehav Rev. 2010;34:755-68.
28. Lopez-Wagner MC, Hoffman CD, Sweeney DP, Hodge D, Gilliam JE. Sleep problems of parents of typically developing children and parents of children with autism. J Genet Psychol. 2008;169:245-59.
29. Järbrink K. The economic consequences of autistic spectrum disorder among children in a Swedish municipality. Autism. 2007;11:453-63.
30. Cimera RE, Cowan RJ. The costs of services and employment outcomes achieved by adults with autism in the US. Autism. 2009;13:285-302.
31. Golnik A, Ireland M, Borowsky IW. Medical homes for children with autism: A physician survey. Pediatrics. 2009;123: 966-71.
32. Stoltenberg C, Schjølberg S, Bresnahan M, Hornig M, Hirtz D, Dahl C, et al. ABC Study Group. The Autism Birth Cohort: A paradigm for gene-environment-timing research. Mol Psychiatry. 2010;15:676-80.
33. Li YF, Langholz B, Salam MT, Gilliland FD. Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest. 2005;127:1232-41.
34. Schanen NC. Epigenetic of autism spectrum disorders. Hum Mol Genet. 2006;15:R138-50.
35. Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I, et al. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res. 2008; 1:169-78.
36. Dietert RR, Dietert JM. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: Focus on critical windows of immune vulnerability. J Toxicol Environ Health B Crit Rev. 2008;11: 660-80.
37. Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci. 2005;23:189-99.
38. Bilder D, Pinborough-Zimmerman J, Miller J, McMahon W. Prenatal, perinatal, and neonatal factors associated with autism spectrum disorders. Pediatrics. 2009;123:1293-300.
39. Dufour-Rainfray D, Vourc'h P, Le Guisquet AM, Garreau L, Ternant D, Bodard S, et al. Behavior and serotonergic disorders in rats exposed prenatally to valproate: A model for autism. Neurosci Lett. 2010;470:55-9.
40. Buchmayer S, Johansson S, Johansson A, Hultman CM, Sparén P, Cnattingius S. Can association between preterm birth and autism be explained by maternal or neonatal morbidity? Pediatrics. 2009;124:e817-25.
41. Schlotz W, Phillips DI. Fetal origins of mental health: Evidence and mechanisms. Brain Behav Immun. 2009;23: 905-16.
42. Johansson M, Wentz E, Fernell E, Strömland K, Miller MT, Gillberg C. Autistic spectrum disorders in Möbius sequence: A comprehensive study of 25 individuals. Dev Med Child Neurol. 2001;43:338-45.
43. Rinaldi T, Kulangara K, Antoniello K, Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci USA. 2007;104:13501-6.
44. Brown GE, Jones SD, MacKewn AS, Plank EJ. An exploration of possible pre- and postnatal correlates of autism: A pilot survey. Psychol Rep. 2008;102:273-82.
45. Ploeger A, Raijmakers ME, van der Maas HL, Galis F. The association between autism and errors in early embryogenesis: What is the causal mechanism? Biol Psychiatry. 2010;67:602-7.
46. Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord. 2003;33: 455-9.
47. Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG, et al. Autism and environmental genomics. Neurotoxicology. 2006;27:671-84.
48. Herbert MR. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol. 2010;23:103-10.
49. Grice DE, Buxbaum JD. The genetics of autism spectrum disorders. Neuromolecular Med. 2006;8:451-60.
50. Gilbert SG (Institute of Neurotoxicology and Neurological Disorders). Scientific consensus statement on environmental agents associated with neurodevelopmental disorders. Collaborative on Health and the Environment's Learning and Developmental Disabilities Initiative; 2008 July 1 [accessed 2010 July 6]. Available from: http://www.iceh.org/pdfs/LDDI/LDDIStatement.pdf
51. Daniels JL. Autism and the environment. Environ Health Perspect. 2006;114:A396.
52. Kern JK, Grannemann BD, Trivedi MH, Adams JB. Sulfhydryl-reactive metals in autism. J Toxicol Environ Health A. 2007;70:715-21.
53. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, et al. The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J Toxicol. 2009: 532-640.
54. Roberts EM, English PB, Grether JK, Windham GC, Somber L, Wolff C. Maternal residence near agriculture pesticide applications and autism spectrum disorders among children in the California central valley. Environ Health Perspect. 2007;115:1482-9.
55. Messer A. Mini-review: Polybrominated dipenyl ether (PBDE) flame retardants as potential autism risk factors. Physiol Behav. 2010;100:245-9.
56. Kuroda Y. Effects of endocrine disruptors on brain development* Development of novel assay systems for risk assessment. Environ Sci. 2003;10 suppl: 23-33.
57. Kimura-Kuroda J, Nagata I, Kuroda Y. Disrupting effects of hydroxyl-polychlorinated biphenyl (PCB) congeners on neuronal development of cerebellar Purkinje cells: A possible causal factor for developmental brain disorders? Chemosphere. 2007;67:S412-20.
58. Torres AR. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatr. 2003;3:9.
59. Alsdorf R, Wyszynski DF. Teratogenicity of sodium valproate. Expert Opin Drug Saf. 2005;4:345-53.
60. Ornoy A. Valproic acid in pregnancy: How much are we endangering the embryo and fetus? Reprod Toxicol. 2009; 28:1-10.
61. Bromley RL, Mawer G, Clayton-Smith J, Baker GA. Liverpool and Manchester Neurodevelopment Group. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology. 2008;71:1923-4.
62. Kolozsi E, Mackenzie RN, Roullet FI, deCatanzaro D, Foster JA. Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. Neuroscience. 2009;163:1201-10.
63. Narita M, Oyabu A, Imura Y, Kamada N, Yokoyama T, Tano K, et al. Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat. Neurosci Res. 2010;66:2-6.
64. Schneider T, Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology. 2005;30:80-9.
65. Schneider T, Ziòłkowska B, Gieryk A, Tyminska A, Przewłocki R. Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. Psychopharmacology (Berl). 2007;193:547-55.
66. Schneider T, Roman A, Basta-Kaim A, KuberaM, Budziszewska B, Schneider K, et al. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology. 2008;33:728-40.
67. Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, et al. Identification of a primary target of thalidomide teratogenicity. Science. 2010;327:1345-50.
68. Strömland K, Nordin V, Miller M, Akerström B, Gillberg C. Autism in thalidomide embryopathy: A population study. Dev Med Child Neurol. 1994;36:351-6.
69. Rodier PM. Converging evidence for brain stem injury in autism. Dev Psychopathol. 2002;14:537-57.
70. Bandim JM, Ventura LO, Miller MT, Almeida HC, Costa AE. Autism and Möbius sequence: An exploratory study of children in northeastern Brazil. Arq Neuropsiquiatr. 2003;61: 181-5.
71. Witter FR, Zimmerman AW, Reichmann JP, Connors SL. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol. 2009;201:553-9.
72. Zerrate MC, Pletnikov M, Connors SL, Vargas DL, Seidler FJ, Zimmerman AW, et al. Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: Implications for autism. J Pharmacol Exp Ther. 2007;322: 16-22.
73. Enstrom AM, Onore CE, Van de Water JA, Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2010;24: 64-71.
74. Schultz ST, Klonoff-Cohen HS, Wingard DL, Akshoomoff NA, Macera CA, Ji M. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: The results of a parent survey. Autism. 2008;12:293-307.
75. Cannell JJ. Autism and vitamin D. Med Hypotheses. 2008;70: 750-9.
76. Currenti SA. Understanding and determining the etiology of autism. Cell Mol Neurobiol. 2010;30:161-71.
77. Grant WB, Soles CM. Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermatoendocrinology. 2009;1:223-8.
78. Fernell E, Barnevik-Olsson M, Bågenholm G, Gillberg C, Gustafsson S, Sää f M. Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism. Acta Paediatr. 2010;99:743-7.
79. Moore M, Piazza A, Nolan Y, Lynch MA. Treatment with dexamethasone and vitamin D3 attenuates neuroinflammatory age-related changes in rat hippocampus. Synapse. 2007;61: 851-61.
80. Kinney DK, Barch DH, Chayka B, Napoleon S, Munir KM. Environmental risk factors for autism: Do they help cause de novo genetic mutations that contribute to the disorder? Med Hypotheses. 2010;74:102-6.
81. James SJ, Melnyk S, Jernigan S, Pavliv O, Trusty T, Lehman S, et al. A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. Am J Med Genet B Neuropsychiatr Genet. 2010;153B: 1209-20.
82. Greenblatt JM, Huffman LC, Reiss AL. Folic acid in neurodevelopment and child psychiatry. Prog Neuropsychopharmacol Biol Psychiatry. 1994;18:647-60.
83. Julvez J, Fortuny J, Mendez M, Torrent M, Ribas-Fitó N, Sunyer J. Maternal use of folic acid supplements during pregnancy and four-year-old neurodevelopment in a population-based birth cohort. Paediatr Perinat Epidemiol. 2009;23:199-206.
84. Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007;38:276-81.
85. Main PA, Angley MT, Thomas P, O'Doherty CE, Fenech M. Folate and methionine metabolism in autism: A systematic review. Am J Clin Nutr. 2010;91:1598-620.
86. Patterson PH. Immune involvement in schizophrenia and autism: Etiology, pathology and animal models. Behav Brain Res. 2009;204:313-21.
87. Brown AS, Derkits EJ. Prenatal infection and schizophrenia: A review of epidemiologic and translational studies. Am J Psychiatry. 2010;167:261-80.
88. Nawa H, Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines. Neurosci Res. 2006;56:2-13.
89. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. Autistic disorder and viral infections. J Neurovirol. 2005;11: 1-10.
90. Hwang SJ, Chen YS. Congenital rubella syndrome with autistic disorder. J Chin Med Assoc. 2010;73:104-7.
91. Fortier ME, Luheshi GN, Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res. 2007;181:270-7.
92. Atladóttir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010;40:1423-30.
93. Girard S, Tremblay L, Lepage M, Sébire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol. 2010;184:3997-4005.
94. Dietert RR. Distinguishing environmental causes of immune dysfunction from pediatric trigger of disease. Open Pediatr Med J. 2009;3:38-44.
95. Uchiyama T, Kurosawa M, Inaba Y. MMR-vaccine and regression in autism spectrum disorders: Negative results presented from Japan. J Autism Dev Disord. 2007;37:210-7.
96. Baird G, Pickles A, Simonoff E, Charman T, Sullivan P, Chandler S, et al. Measles vaccination and antibody response in autism spectrum disorders. Arch Dis Child. 2008;93:832-7.
97. Mrozek-Budzyn D, Kiełtyka A, Majewska R. Lack of association between measles-mumps-rubella vaccination and autism in children: A case-control study. Pediatr Infect Dis J. 2010;29:397-400.
98. House RV. Fundamentals of clinical immunotoxicology. Methods Mol Biol. 2010;598:363-84.
99. McDonald KL, Huq SI, Lix LM, Becker AB, Kozyrskyj AL. Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma. J Allergy Clin Immunol. 2008;121:626-31.
100. Cohly HH, Panja A. Immunological findings in autism. Int Rev Neurobiol. 2005;71:317-41.
101. Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, et al. Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol. 2008;204:149-53.
102. Beversdorf DQ, Manning SE, Hillier A, Anderson SL, Nordgren RE, Walters SE, et al. Timing of prenatal stressors and autism. J Autism Dev Disord. 2005;35:471-8.
103. Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci. 2008;28:9055-65.
104. Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the brain: Implications for explaining autism. Science. 2005;310:819-23.
105. Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, Hackett G. Fetal testosterone and autistic traits. Br J Psychol. 2009;100(Pt 1):1-22.
106. Jones KL, Smith RM, Edwards KS, Givens B, Tilley MR, Beversdorf DQ. Combine effect of maternal serotonin transporter genotype and prenatal stress in modulating offspring social interaction in mice. Int J Dev Neurosci. 2010;28:529-36.
107. Li J, Vestergaard M, Obel C, Christensen J, Precht DH, Lu M, et al. A nationwide study on the risk of autism after prenatal stress exposure to maternal bereavement. Pediatrics. 2009;123: 1102-7.
108. Gluckman PD, Hanson MA, Mitchell MD. Developmental origins of health and disease: Reducing the burden of chronic disease in the next generation. Genome Med. 2010;2:14.
109. Miyazaki K, Narita N, Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: Implication for pathogenesis of autism. Int J Dev Neurosci. 2005;23:287-97.
110. Fatemi SH, Folsom TD, Reutiman TJ, Huang H, Oishi K, Mori S. Prenatal viral infection of mice at E16 causes changes in gene expression in hippocampi of the offspring. Eur Neuropsychopharmacol. 2009;19:648-53.
111. Connors SL, Crowell DE, Eberhart CG, Copeland J, Newschaffer CJ, Spence SJ, et al. Beta2-adrenergic receptor activation and genetic polymorphisms in autism: Data from dizygotic twins. J Child Neurol. 2005;20:876-84.